Zacks_SCR_Research_08242022_EDSA_Bautz.pdf (q4cdn.com)
Analyst Expectations for Centene’s Future
Within the last quarter, Centene (NYSE:CNC) has observed the following analyst ratings: Bullish Somewhat Bullish Indifferent Somewhat Bearish…
Zacks Small-Cap Research Sets $15 Valuation On Edesa Biotech
Zacks_SCR_Research_08242022_EDSA_Bautz.pdf (q4cdn.com)
Related Posts
Paramount Global Shares Drop After Q4 Consensus Miss, Paramount+ Reaches 56M Subscribers
Paramount Global (NASDAQ:PARA) reported fourth-quarter FY22 revenue growth of 2% year-on-year to $8.13 billion, missing the consensus of $8.16 billion.…
Constellation Brands Q4 Highlights: 5% Sales Decline, Bottomline Beat, Dividend Hike & More
Constellation Brands, Inc. (NYSE:STZ) reported a fourth-quarter FY23 sales decline of 5% year-on-year to $1.997 billion, missing the consensus of $2.02…
Tesla Granted U.S. Patent #11567514: Autonomous And User Controlled Vehicle Summon To A Target
https://www.scribd.com/document/622936429/TSLA-Patent